Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01DDB
|
|||
| Former ID |
DNC006065
|
|||
| Drug Name |
2-(Phenylamino)-6-(3-acetamidophenyl)pyrazine
|
|||
| Synonyms |
CHEMBL425576; 2-(Phenylamino)-6-(3-acetamidophenyl)pyrazine; SCHEMBL1122285
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C18H16N4O
|
|||
| Canonical SMILES |
CC(=O)NC1=CC=CC(=C1)C2=CN=CC(=N2)NC3=CC=CC=C3
|
|||
| InChI |
1S/C18H16N4O/c1-13(23)20-16-9-5-6-14(10-16)17-11-19-12-18(22-17)21-15-7-3-2-4-8-15/h2-12H,1H3,(H,20,23)(H,21,22)
|
|||
| InChIKey |
MKRMZWIJCMWBDU-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Novel inhibitors of B-RAF based on a disubstituted pyrazine scaffold. Generation of a nanomolar lead. J Med Chem. 2006 Jan 12;49(1):407-16. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.